Please select an option below to help us tailor your newsletter to best suit your content interests!
Brain Cancer patients in the Mid-South now have a promising new treatment method at West Cancer Center, the first of its kind in the region. Optuneā¢, a portable device that uses low intensity electric fields to inhibit cancer cell replication causing death of cancer cells. Optuneā¢ is the first FDA-approved therapy in more than a… Read more »
A new advanced cancer support drug with local ties to Memphis has been approved by the U.S. Food and Drug Administration (FDA). Rolapitant (Varubiā¢), developed by Tesaro, Inc., has been approved by the FDA for the prevention of chemotherapy-induced nausea and vomiting (CINV). The drug received approval as a result of three phase III clinical… Read more »
Newly formed Memphis Breast Cancer Consortium launches āSister Pactā ā an initiative toĀ encourage regular breast cancer screening, as appropriate, and provide information aboutĀ local breast health services, such as free or low-cost mammograms. New Community Educational Program Aims to Help Address Breast Cancer Survival Disparity of African-American Women in Memphis Memphis ā August 29, 2015 ā… Read more »